Delivery Order SPE2DB20D1109-SPE2DB25FP75Y
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $4,416.12 to AmerisourceBergen Drug Corp for the supply of Nucynta ER 100 mg tablets (60-count packages) on August 20, 2025, with a completion date of August 21, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract falls under AmerisourceBergen's existing Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $2,944.08 to AmerisourceBergen Drug Corp for the supply of Nucynta ER 100 mg tablets (60-count packages) with a completion date of August 11, 2025. This competitively awarded, non-set-aside contract operates under a firm fixed price arrangement and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical distributor, headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $1,899.74 to AmerisourceBergen Drug Corp for the supply of Nucynta ER 150 mg tablets (60-count units) on August 5, 2025, with an ultimate completion date of August 6, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The order represents a child contract action under...
- The Defense Logistics Agency awarded a $3,614.98 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Nucynta ER 100 mg tablets (60-count bottles). This is a non-set-aside contract with an ultimate completion date of September 18, 2025. The place of performance is AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a $1,562.38 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Nucynta ER 150 mg tablets (60-count units). This non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The prime vendor contract serves as a comprehensive global pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Nucynta ER 100 mg tablets (60-count) with a ceiling value of $1,400.62. This competitive, non-set-aside delivery order represents a firm fixed price contract with an ultimate completion date of August 27, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Nucynta ER 50 mg tablets (60-count) under a firm fixed-price contract valued at $1,194.33. The award, issued on August 18, 2025, represents a non-set-aside competitive award with an ultimate completion date of August 19, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery order from its corporate office...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Nucynta ER 200 mg tablets (60-count units) valued at $6,544.05 under a firm fixed-price contract type. The award, issued on September 2, 2025, with an ultimate completion date of September 3, 2025, represents a non-set-aside, competitively awarded procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery order at its...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,941.77 to AmerisourceBergen Drug Corp for the supply of Nucynta ER 200 mg tablets (60-count units) on August 29, 2025, with a completion date of September 2, 2025. The contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Nucynta ER 200 mg tablets (60-count) valued at $3,282.96 under a firm fixed price contract type. The contract was competitively awarded without set-aside designation and is scheduled for completion by September 2, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the delivery from its corporate office location in...
- SPE2DB20D1109Indefinite Delivery Contract
- SPE2DB20D1109-SPE2DB25FP75YDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $4,138.41 to AmerisourceBergen Drug Corp for the supply of Nucynta ER 100 mg tablets (60-count units) on September 16, 2025, with completion expected by September 17, 2025. The contract employs firm fixed pricing with no set-aside designation, indicating competitive award through open procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfills this order as a child contract under its larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime contract vehicle extending through December 2026. The delivery order represents a routine pharmaceutical procurement supporting military healthcare supply chains. AmerisourceBergen Drug Corp's federal contract portfolio demonstrates extensive capability in supplying brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic areas to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This award exemplifies the company's established role as a critical vendor within the DLA's pharmaceutical distribution network, which the agency is planning to expand through upcoming Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple regional awards.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.1k | 9/16/25 |